{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T05:33:41Z","timestamp":1738388021988,"version":"3.35.0"},"reference-count":21,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2025,1,31]]},"DOI":"10.1248\/bpb.b24-00687","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:13:52Z","timestamp":1738275232000},"page":"80-85","source":"Crossref","is-referenced-by-count":0,"title":["Change in Vancomycin Absorption after Intraperitoneal Injection and Correlation between Intraperitoneal Vancomycin Absorption and Peritoneal Equilibration Test Score in Mice with Peritoneal Injuries"],"prefix":"10.1248","volume":"48","author":[{"given":"Akihiro","family":"Moritsuka","sequence":"first","affiliation":[{"name":"Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852\u20138521, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852\u20138521, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukina","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852\u20138521, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruna","family":"Hirata","sequence":"additional","affiliation":[{"name":"Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852\u20138521, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Kawauchi","sequence":"additional","affiliation":[{"name":"Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852\u20138521, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Fumoto","sequence":"additional","affiliation":[{"name":"Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852\u20138521, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koyo","family":"Nishida","sequence":"additional","affiliation":[{"name":"Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852\u20138521, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. <i>Kidney Int<\/i>., <b>62<\/b>, 1046\u20131053 (2002).","DOI":"10.1046\/j.1523-1755.2002.00505.x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Govindarajulu S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW. Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. <i>Perit. Dial. Int<\/i>., <b>30<\/b>, 311\u2013319 (2010).","DOI":"10.3747\/pdi.2008.00258"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Morse GD, Farolino DF, Apicella MA, Walshe JJ. Comparative study of intraperitoneal and intravenous vancomycin pharmacokinetics during continuous ambulatory peritoneal dialysis. <i>Antimicrob. Agents Chemother<\/i>., <b>31<\/b>, 173\u2013177 (1987).","DOI":"10.1128\/AAC.31.2.173"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Bastani B, Spyker DA, Westervelt FB Jr. Peritoneal absorption of vancomycin during and after resolution of peritonitis in continuous ambulatory peritoneal dialysis (CAPO) patients. <i>Perit. Dial. Int<\/i>., <b>8<\/b>, 135\u2013136 (1988).","DOI":"10.1177\/089686088800800205"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Hirata H, Miyamoto H, Shimokawa K, Nakashima M, Nakayama M, Fumoto S, Nishida K. Novel diagnostic method of peritoneal injury using dual macromolecular markers. <i>Biol. Pharm. Bull<\/i>., <b>37<\/b>, 262\u2013267 (2014).","DOI":"10.1248\/bpb.b13-00730"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Karl ZJT, Khanna ONR, Leonor BFP, Ryan P, Moore HL, Nielsen MP. Peritoneal equilibration test. <i>Perit. Dial. Int<\/i>., <b>7<\/b>, 138\u2013148 (1987).","DOI":"10.1177\/089686088700700306"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Arai H, Furusu A, Nishino T, Obata Y, Nakazawa Y, Nakazawa M, Hirose M, Abe K, Koji T, Kohno S. Thalidomide prevents the progression of peritoneal fibrosis in mice. <i>Acta Histochem. Cytochem<\/i>., <b>44<\/b>, 51\u201360 (2011).","DOI":"10.1267\/ahc.10030"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Duan WJ, Yu X, Huang XR, Yu JW, Lan HY. Opposing roles for Smad2 and Smad3 in peritoneal fibrosis <i>in vivo<\/i> and <i>in vitro<\/i>. <i>Am. J. Pathol<\/i>., <b>184<\/b>, 2275\u20132284 (2014).","DOI":"10.1016\/j.ajpath.2014.04.014"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kawai S, Takagi Y, Kaneko S, Kurosawa T. Effect of three types of mixed anesthetic agents alternate to ketamine in mice. <i>Exp. Anim<\/i>., <b>60<\/b>, 481\u2013487 (2011).","DOI":"10.1538\/expanim.60.481"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Plock N, Buerger C, Kloft C. Successful management of discovered pH dependence in vancomycin recovery studies: novel HPLC method for microdialysis and plasma samples. <i>Biomed. Chromatogr<\/i>., <b>19<\/b>, 237\u2013244 (2005).","DOI":"10.1002\/bmc.446"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Fumoto S, Nakashima Y, Nishida K, Kodama Y, Nishi J, Nakashima M, Sasaki H, Otsuka N, Nakamura J. Evaluation of enhanced peritoneum permeability in methylglyoxal-treated rats as a diagnostic method for peritoneal damage. <i>Pharm. Res<\/i>., <b>24<\/b>, 1891\u20131896 (2007).","DOI":"10.1007\/s11095-007-9313-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Nakayama M, Sakai A, Numata M, Hosoya T. Hyper-vascular change and formation of advanced glycation endproducts in the peritoneum caused by methylglyoxal and the effect of an anti-oxidant, sodium sulfite. <i>Am. J. Nephrol<\/i>., <b>23<\/b>, 390\u2013394 (2003).","DOI":"10.1159\/000074065"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Mondello S, Mazzon E, Di Paola R, Crisafulli C, Mondello P, Buemi M, Aloisi C, Cuzzocrea S. Thalidomide suppresses sclerosing encapsulating peritonitis in a rat experimental model. <i>Shock<\/i>, <b>32<\/b>, 332\u2013339 (2009).","DOI":"10.1097\/SHK.0b013e3181994974"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Hirahara I, Sato H, Imai T, Onishi A, Morishita Y, Muto S, Kusano E, Nagata D. Methylglyoxal induced basophilic spindle cells with podoplanin at the surface of peritoneum in rat peritoneal dialysis model. <i>BioMed Res. Int<\/i>., <b>2015<\/b>, 289751 (2015).","DOI":"10.1155\/2015\/289751"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Sinha Ray A, Haikal A, Hammoud KA, Yu AS. Vancomycin and the risk of AKI: a systematic review and meta-analysis. <i>Clin. J. Am. Soc. Nephrol<\/i>., <b>11<\/b>, 2132\u20132140 (2016).","DOI":"10.2215\/CJN.05920616"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ye ZK, Tang HL, Zhai SD. Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis. <i>PLOS ONE<\/i>, <b>8<\/b>, e77169 (2013).","DOI":"10.1371\/journal.pone.0077169"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Pritchard L, Baker C, Leggett J, Sehdev P, Brown A, Bayley KB. Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity. <i>Am. J. Med<\/i>., <b>123<\/b>, 1143\u20131149 (2010).","DOI":"10.1016\/j.amjmed.2010.07.025"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, Mueller BA, Pai MP, Wong-Beringer A, Rotschafer JC, Rodvold KA, Maples HD, Lomaestro BM. Therapeutic monitoring of vancomycin for serious methicillin-resistant <i>Staphylococcus aureus<\/i> infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. <i>Am. J. Health Syst. Pharm<\/i>., <b>77<\/b>, 835\u2013864 (2020).","DOI":"10.1093\/ajhp\/zxaa036"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Ballinger AE, Palmer SC, Wiggins KJ, Craig JC, Johnson DW, Cross NB, Strippoli GFM. Treatment for peritoneal dialysis-associated peritonitis. <i>Cochrane Database Syst. Rev<\/i>., 2014, CD005284 (2014).","DOI":"10.1002\/14651858.CD005284.pub3"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Golper TA, Noonan HM, Elzinga L, Gilbert D, Brummett R, Anderson JL, Bennett WM. Vancomycin pharmacokinetics, renal handling, and nonrenal clearances in normal human subjects. <i>Clin. Pharmacol. Ther<\/i>., <b>43<\/b>, 565\u2013570 (1988).","DOI":"10.1038\/clpt.1988.74"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Hori Y, Aoki N, Kuwahara S, Hosojima M, Kaseda R, Goto S, Iida T, De S, Kabasawa H, Kaneko R, Aoki H, Tanabe Y, Kagamu H, Narita I, Kikuchi T, Saito A. Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity. <i>J. Am. Soc. Nephrol<\/i>., <b>28<\/b>, 1783\u20131791 (2017).","DOI":"10.1681\/ASN.2016060606"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/1\/48_b24-00687\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T03:29:23Z","timestamp":1738380563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/48\/1\/48_b24-00687\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b24-00687","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"type":"print","value":"0918-6158"},{"type":"electronic","value":"1347-5215"}],"subject":[],"published":{"date-parts":[[2025,1,31]]},"article-number":"b24-00687"}}